THE DEAL, AT A GLANCE
From the announcementOmri Casspi
01What it doesAn Israeli biotech is betting they can "If you're building a frontier technology, then you don't have growth" Omri Casspi.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by seed through growthFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedOmri Casspi raised $250M Pre-Seed, announced 2026-09-03From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersOmri Casspi's $250M Pre-Seed financing is a 90th percentile Healthcare & Life Sciences round in the Capvizr dataset, positioning the deal as a large-capital signal…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Omri Casspi · Financing Record
Explore source-linked visual explanations for Omri Casspi. Unsupported claims are withheld while source review continues.
Record 11561 · Recorded date: 2026-09-03
Explore company records →